"CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs (CONTINUUM)"

NATerminatedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

September 18, 2018

Study Completion Date

September 19, 2018

Conditions
Superficial Femoral Artery Stenosis
Interventions
DEVICE

PTA followed by placement of LifeStent® Vascular Stent

PTA followed by placement of LifeStent® Vascular Stent

Trial Locations (29)

11743

The Huntington Heart Center, Huntington

15212

Allegheny-Singer Research Institute, Pittsburgh

16502

Saint Vincent Consultants in Cardiovascular Diseases, LLC, Erie

17043

PinnacleHealth Cardiovascular Institute, Wormleysburg

19104

Trustees of the University of Pennsylvania, Philadelphia

29204

South Carolina Heart Center, P.A., Columbia

29501

McLeod Regional Medical Center, Florence

33140

Mount Sinai Medical Center, Miami Beach

33176

Baptist Hospital of Miami, Miami

33308

South Florida Medical Imaging, PA, Fort Lauderdale

37403

University Surgical Associates, LLC, Chattanooga

41101

Kentucky Heart Foundation, Ashland

46321

Cardiovascular Research of Northwest Indiana, LLC., Munster

49509

Metropolitan Hospital d/b/a Metro Health Hospital, Wyoming

53215

Aurora Medical Group, Milwaukee

57104

Sanford Research, Sioux Falls

60435

Heartland Vascular Center, Joliet

60637

Loyola University Chicago, Chicago

62701

Prairie Education and Research Cooperative (PERC), Springfield

64116

Midwest Aortic Vascular Institute P.C, North Kansas City

66160

University of Kansas Medical Center Research Institute, Inc., Kansas City

77030

Houston Center for Vascular Health, Houston

The Methodist Hospital Research Institute dba Houston Methodist Research Institute, Houston

77845

BCS Heart, LLP., College Station

90073

VA Greater Los Angeles Healthcare System, Los Angeles

94588

Mission Cardiovascular Research Institute, Pleasanton

02135

Steward St. Elizabeth Medical Center of Boston Inc., Boston

08103

The Cooper Health System, Camden

08901

Saint Peter's University Hospital, New Brunswick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT00908947 - "CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs (CONTINUUM)" | Biotech Hunter | Biotech Hunter